Stroke Trial, Recruiting (NCT07231172)

Stroke Trial, Recruiting NCT07231172 Sponsor: Ankara University Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT07231172 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a stroke, as defined by the World Health Organization
You are 18 years of age or older
Your stroke has been confirmed by a CT scan and/or MRI scan
It has been at least 3 months since your stroke
You are able to walk at least some of the time, either with or without help, meeting a certain level on a walking ability scale (confirm with trial site)
You have agreed to take part and have signed a consent form

Who may not be able to join:

You have had a stroke before the one being considered for this trial
You have communication difficulties, for example due to language or speech problems after stroke, or dementia
You are unable to read or write
You have memory or thinking difficulties that make it hard to follow instructions, based on a standard test score (confirm with trial site)
You have a condition such as cancer, heart failure, liver failure, or kidney failure that may cause tiredness or fatigue
You currently show signs of an infection affecting your body
You have a history of a specific type of bleeding in the brain called subarachnoid hemorrhage

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ayşe A. Küçükdeveci, Prof, Ankara University

Phone: +903125082822

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07231172

Sponsor: Ankara University

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +903125082822

More information: https://clinicaltrials.gov/study/NCT07231172

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a stroke, as defined by the World Health Organization
You are 18 years of age or older
Your stroke has been confirmed by a CT scan and/or MRI scan
It has been at least 3 months since your stroke
You are able to walk at least some of the time, either with or without help, meeting a certain level on a walking ability scale (confirm with trial site)
You have agreed to take part and have signed a consent form

Who may not be able to join:

You have had a stroke before the one being considered for this trial
You have communication difficulties, for example due to language or speech problems after stroke, or dementia
You are unable to read or write
You have memory or thinking difficulties that make it hard to follow instructions, based on a standard test score (confirm with trial site)
You have a condition such as cancer, heart failure, liver failure, or kidney failure that may cause tiredness or fatigue
You currently show signs of an infection affecting your body
You have a history of a specific type of bleeding in the brain called subarachnoid hemorrhage

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ankara University

Registry

ClinicalTrials.gov

Start date

21 November 2024

Est. completion

29 January 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Fatigue Severity Scale; Visual Analog Scale-Fatigue

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov